Table VIII.
Distribution of savings associated with trips avoided, by ATC1 code
| ATC1 Code | Savings associated with trips avoided | Avoided labor productivitylosses | ||
|---|---|---|---|---|
| € | % | € | % | |
| A - Alimentary tract and metabolism | 230 | 2.6% | 343 | 2.4% |
| B - Blood and blood-forming organs | 996 | 11.2% | 1,527 | 10.6% |
| C - Cardiovascular system | 581 | 6.5% | 1,034 | 7.2% |
| D - Dermatological | 28 | 0.3% | 47 | 0.3% |
| G - Genitourinary system and sex hormones | 23 | 0.3% | 44 | 0.3% |
| H - Systemic hormonal preparations, excluding sex hormones and insulins | 220 | 2.5% | 324 | 2.3% |
| J - Anti-infectives for systemic use | 749 | 8.4% | 1,208 | 8.4% |
| L - Antineoplastic and immunomodulating agents | 5,596 | 62.8% | 9,081 | 63.1% |
| N - Nervous system | 283 | 3.2% | 470 | 3.3% |
| R - Respiratory system | 126 | 1.4% | 197 | 1.4% |
| S - Sensory organs | 67 | 0.8% | 117 | 0.8% |
| V - Miscellaneous | 7 | 0.1% | 10 | 0.1% |
| Total | 8,907 | 100% | 14,402 | 100% |